Toggle Main Menu Toggle Search

Open Access padlockePrints

MRI and MRS alterations in the preclinical phase of murine prion disease: Association with neuropathological and behavioural changes

Lookup NU author(s): Professor Andrew BlamireORCiD

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.


Abstract

Prion diseases are fatal chronic neurodegenerative diseases. Previous qualitative magnetic resonance imaging (MRI) and spectroscopy (MRS) studies report conflicting results in the symptomatic stages of the disease, but little work has been carried out during the earlier stages of the disease. Here we have used the murine ME7 model of prion disease to quantitatively investigate MRI and MRS changes during the period prior to the onset of overt clinical signs (20+ weeks) and have correlated these with pathological and behavioural abnormalities. Using in vivo MRI, at the later stages of the preclinical period (18 weeks) the diffusion of tissue water was significantly reduced, coinciding with significant microglial activation and behavioural hyperactivity. Using in vivo MRS, we found early (12 weeks) decreases in the ratio of N-acetyl aspartate to both choline (NAA/Cho) and creatine (NAA/Cr) in the thalamus and hippocampus, which were associated with early behavioural deficits. Ex vivo MRS of brain extracts confirmed and extended these findings, showing early (8-12 weeks) decreases in both the neuronal metabolites NAA and glutamate, and the metabolic metabolites lactate and glucose. Increases in the glial metabolite myo-inositol were observed at later stages when microglial and astrocyte activation is substantial. These changes in MRI and MRS signals, which precede overt clinical signs of disease, could provide insights into the pathogenesis of this disease and may enable early detection of pathology. © 2007 Elsevier Inc. All rights reserved.


Publication metadata

Author(s): Broom KA, Anthony DC, Lowe JP, Griffin JL, Scott H, Blamire AM, Styles P, Hugh Perry V, Sibson NR

Publication type: Article

Publication status: Published

Journal: Neurobiology of Disease

Year: 2007

Volume: 26

Issue: 3

Pages: 707-717

ISSN (print): 0969-9961

ISSN (electronic): 1095-953X

Publisher: Academic Press

URL: http://dx.doi.org/10.1016/j.nbd.2007.04.001

DOI: 10.1016/j.nbd.2007.04.001

PubMed id: 17490889


Altmetrics

Altmetrics provided by Altmetric


Funding

Funder referenceFunder name
G0300456Medical Research Council

Share